Multiple organ failure related to pantoprazole [6]

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 6, 1999, Pages 833-834

  Yusoff, I F ^a   Nairn, P ^b   Morgan, C A ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; CYTOCHROME P450 2C19; FAMOTIDINE; NAPROXEN; OMEPRAZOLE; PANTOPRAZOLE; PARACETAMOL;

AGED; CASE REPORT; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMAN; KIDNEY FAILURE; LACTIC ACIDOSIS; LETTER; LIVER FAILURE; MALE; MULTIPLE ORGAN FAILURE; MUSCLE BIOPSY; RHABDOMYOLYSIS;

EID: 0033403240     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00796.x     Document Type: Letter

References (6)

1. 1. Jochem V, Kirkpatrick R, Greenson J, Brogan M, Sturgis T, Cook-Glen C. Fulminant hepatic failure related to omeprazole. Am J Gastro 1992; 87: 523-5.
2. 2. Del Rio Frenandez M, Plagaro Cordero ME, de Frutos Arribar JF, Bellido Casado J, Velicia Hanei R. Hepatic encephalopathy related to omeprazole. Revision Espanola de Entermedades Digestivan 1997; 89: 574-5.
3. 3. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
4. 4. Steinijans VW, Huber R, Hartman M et al. Lack of pantoprazole drug interactions in man. Clin Pharmacol Ther 1994; 32: 385-99.
5. 5. Schafer DF, Sorrell MF. Power failure, liver failure (editorial). N Engl J Med 1997; 336: 1173-4.
6. 6. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101-54.